Literature DB >> 26774676

Molecular mechanisms of curcumins suppressing effects on tumorigenesis, angiogenesis and metastasis, focusing on NF-κB pathway.

Yunes Panahi1, Behrad Darvishi2, Mostafa Ghanei1, Narges Jowzi3, Fatemeh Beiraghdar4, Behrang Shiri Varnamkhasti3.   

Abstract

NF-κB pathway has long been considered as one of the potent prototypical pro-inflammatory signaling pathway and its role in several aspects of human health has been established. Recent studies have suggested that NF-κB activation is the master key in early development and pathobiology of several Cancers. Curcumin is a polyphenolic phytochemical compound with several stablished anti-inflammatory properties and is known to exert its anti-inflammatory effects mostly by interrupting NF-κB signaling pathway at multiple stages. Here we tried to provide a summary of recent finding, focusing on introducing NF-κB signaling pathways and its potential mechanism involved in development of several types of Cancers.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Curcumin; Inflammation; NF-κB

Mesh:

Substances:

Year:  2016        PMID: 26774676     DOI: 10.1016/j.cytogfr.2015.12.004

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  21 in total

1.  Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Authors:  Alina Sesarman; Lucia Tefas; Bianca Sylvester; Emilia Licarete; Valentin Rauca; Lavinia Luput; Laura Patras; Sebastian Porav; Manuela Banciu; Alina Porfire
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

Review 2.  Antitumor Potential of Immunomodulatory Natural Products.

Authors:  Genoveffa Nuzzo; Giuseppina Senese; Carmela Gallo; Federica Albiani; Lucia Romano; Giuliana d'Ippolito; Emiliano Manzo; Angelo Fontana
Journal:  Mar Drugs       Date:  2022-06-08       Impact factor: 6.085

Review 3.  Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/β-catenin signalling pathways.

Authors:  L Farahmand; B Darvishi; K Majidzadeh-A; A Madjid Ansari
Journal:  Cell Prolif       Date:  2016-09-27       Impact factor: 6.831

4.  Curcumin inhibits angiogenesis by up-regulation of microRNA-1275 and microRNA-1246: a promising therapy for treatment of corneal neovascularization.

Authors:  Yanhui Bai; Weiqun Wang; Guangli Sun; Mingchang Zhang; Jingmin Dong
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

Review 5.  Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides.

Authors:  Leila Farahmand; Behrad Darvishi; Keivan Majidzadeh-A
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  Curcumin Anti-Apoptotic Action in a Model of Intestinal Epithelial Inflammatory Damage.

Authors:  Claudia Loganes; Sara Lega; Matteo Bramuzzo; Liza Vecchi Brumatti; Elisa Piscianz; Erica Valencic; Alberto Tommasini; Annalisa Marcuzzi
Journal:  Nutrients       Date:  2017-06-06       Impact factor: 5.717

Review 7.  Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.

Authors:  Behrad Darvishi; Leila Farahmand; Keivan Majidzadeh-A
Journal:  Mol Ther Nucleic Acids       Date:  2017-03-29

8.  Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation.

Authors:  Jürgen Brück; Julia Holstein; Ivana Glocova; Ursula Seidel; Julia Geisel; Toshio Kanno; Jin Kumagai; Naoko Mato; Stephan Sudowe; Katja Widmaier; Tobias Sinnberg; Amir S Yazdi; Franziska C Eberle; Kiyoshi Hirahara; Toshinori Nakayama; Martin Röcken; Kamran Ghoreschi
Journal:  Sci Rep       Date:  2017-03-14       Impact factor: 4.379

9.  An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.

Authors:  Yingxi Du; Yarui Ma; Qing Zhu; Tongzheng Liu; Yuchen Jiao; Peng Yuan; Xiaobing Wang
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

10.  Gallic acid inhibits the release of ADAMTS4 in nucleus pulposus cells by inhibiting p65 phosphorylation and acetylation of the NF-κB signaling pathway.

Authors:  Yao Huang; Jian Chen; Tao Jiang; Zheng Zhou; Bin Lv; Guoyong Yin; Jin Fan
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.